Art

J-GLOBAL ID：202202234615657715   Reference number：22A1168509

Gut microbiota: a potential target for traditional Chinese medicine intervention in coronary heart disease

腸内微生物相: 冠動脈心疾患における漢方薬介入の潜在的標的【JST・京大機械翻訳】

Author (7)： Tian-Yi Cheng, (Faculty of Chinese Medicine, State Key Laboratory of Quality Research in Chinese Medicines, Macau University of Science and Technology, Macau, People’s Republic of China) ,  Jia-Xin Li, (Faculty of Chinese Medicine, State Key Laboratory of Quality Research in Chinese Medicines, Macau University of Science and Technology, Macau, People’s Republic of China) ,  Jing-Yi Chen, (Faculty of Chinese Medicine, State Key Laboratory of Quality Research in Chinese Medicines, Macau University of Science and Technology, Macau, People’s Republic of China) ,  Pei-Ying Chen, (Faculty of Chinese Medicine, State Key Laboratory of Quality Research in Chinese Medicines, Macau University of Science and Technology, Macau, People’s Republic of China) ,  Lin-Rui Ma, (Faculty of Chinese Medicine, State Key Laboratory of Quality Research in Chinese Medicines, Macau University of Science and Technology, Macau, People’s Republic of China) ,  Gui-Lin Zhang, (Faculty of Chinese Medicine, State Key Laboratory of Quality Research in Chinese Medicines, Macau University of Science and Technology, Macau, People’s Republic of China) ,  Pei-Yu Yan, (Faculty of Chinese Medicine, State Key Laboratory of Quality Research in Chinese Medicines, Macau University of Science and Technology, Macau, People’s Republic of China)
Material： Chinese Medicine (Web)
Volume： 16  Issue： 1  Page： 1-20  Publication year： 2021 
JST Material Number： U7464A  ISSN： 1749-8546  Document type： Article
Article type： 文献レビュー  Country of issue： United Kingdom (GBR)  Language： ENGLISH (EN)

Abstract/Point： Coronary heart disease (CHD) i...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=22A1168509&from=J-GLOBAL&jstjournalNo=U7464A") }}

Thesaurus term： metabolite ,  human(primates) ,  People's Republic of China ,  multiplex ,  hypolipidemic drug ,  *enteric microbe ,  microflora ,  *coronary artery disease ,  symptom ,  infrastructure ,  platelet aggregation ,  *Chinese drug
Semi thesaurus term： 腸内フローラ ,  伝達経路 ,  冠動脈拡張症 , 【Automatic Indexing@JST】

Author keywords (3)： Coronary heart disease ,  Gut microbiota ,  Traditional Chinese medicine

JST classification (2)： Basic medicine on cardiovascular system  (GJ01020K) ,  Clinical medicine on cardiovascular system in general  (GJ01030V)

Reference (156)：

• WHO. Cardiovascular diseases (CVDs). World Health Organization, 2021.https://www.who.int/en/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds). Accessed 11 June 2021.
• Chin Circ J; Summary of the 2018 report on cardiovasscular diseases in China; ST Hu, RL Gao, LS Liu, ML Zhu, W Wang, YJ Wang; 034; 003; 2019; 209-220; 10.3969/j.issn.1000-3614.2019.03.001; citation_id=CR2
• Am J Cardiol; Consensus statement role of therapy with "Statins" in patients with hypertriglyceridemia; SM Grundy; 81; 4A; 1998; 1B-6B; 10.1016/s0002-9149(98)00030-7; citation_id=CR3
• Eur J Cardiovasc Nurs; Telehealth interventions for the secondary prevention of coronary heart disease: a systematic review and meta-analysis; K Jin, S Khonsari, R Gallagher, P Gallagher, AM Clark, B Freedman; 18; 4; 2019; 260-271; 10.1177/1474515119826510; citation_id=CR4
• Rev Cardiovasc Med; Diet-induced chronic syndrome, metabolically transformed trimethylamine-N-oxide, and the cardiovascular functions; SJ Hardin, M Singh, W Eyob, JC Molnar, RP Homme, AK George; 20; 3; 2019; 121-128; 10.31083/j.rcm.2019.03.518; citation_id=CR5

Terms in the title (4)： 腸内微生物 ,  冠動脈心疾患 ,  漢方薬 ,  標的